JP2012515168A - 配糖体の2−硫酸化方法 - Google Patents
配糖体の2−硫酸化方法 Download PDFInfo
- Publication number
- JP2012515168A JP2012515168A JP2011545532A JP2011545532A JP2012515168A JP 2012515168 A JP2012515168 A JP 2012515168A JP 2011545532 A JP2011545532 A JP 2011545532A JP 2011545532 A JP2011545532 A JP 2011545532A JP 2012515168 A JP2012515168 A JP 2012515168A
- Authority
- JP
- Japan
- Prior art keywords
- glycoside
- sulfated
- iduronic acid
- ion
- sulfur trioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930182470 glycoside Natural products 0.000 title claims abstract description 86
- 150000002338 glycosides Chemical class 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 46
- 238000005670 sulfation reaction Methods 0.000 title abstract description 15
- -1 iduronic acid glycoside Chemical class 0.000 claims description 48
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 18
- 150000002500 ions Chemical class 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 11
- 150000001241 acetals Chemical class 0.000 claims description 10
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical group O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims description 10
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 9
- 238000004885 tandem mass spectrometry Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 7
- JGFBRKRYDCGYKD-UHFFFAOYSA-N dibutyl(oxo)tin Chemical group CCCC[Sn](=O)CCCC JGFBRKRYDCGYKD-UHFFFAOYSA-N 0.000 claims description 6
- 238000010494 dissociation reaction Methods 0.000 claims description 4
- 230000005593 dissociations Effects 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229910021645 metal ion Chemical group 0.000 claims description 4
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical compound CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- AFDQGRURHDVABZ-UHFFFAOYSA-N n,n-dimethylformamide;sulfur trioxide Chemical compound O=S(=O)=O.CN(C)C=O AFDQGRURHDVABZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000001180 sulfating effect Effects 0.000 claims description 3
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 2
- 229910001415 sodium ion Inorganic materials 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 3
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims 1
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- 239000011541 reaction mixture Substances 0.000 description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- 238000004440 column chromatography Methods 0.000 description 11
- 235000019439 ethyl acetate Nutrition 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 230000019635 sulfation Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 201000002273 mucopolysaccharidosis II Diseases 0.000 description 8
- 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 238000003556 assay Methods 0.000 description 7
- 229960000956 coumarin Drugs 0.000 description 7
- 235000001671 coumarin Nutrition 0.000 description 7
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 4
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- RMZNXRYIFGTWPF-UHFFFAOYSA-N 2-nitrosoacetic acid Chemical compound OC(=O)CN=O RMZNXRYIFGTWPF-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002971 Heparan sulfate Polymers 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- QUMCIHKVKQYNPA-RUZDIDTESA-N C1(CCCCC1)CN1[C@@H](C=2N(C=3C=NC(=NC1=3)NC1=C(C=C(C(=O)NC3CCN(CC3)C)C=C1)OC)C(=NN=2)C)CC Chemical compound C1(CCCCC1)CN1[C@@H](C=2N(C=3C=NC(=NC1=3)NC1=C(C=C(C(=O)NC3CCN(CC3)C)C=C1)OC)C(=NN=2)C)CC QUMCIHKVKQYNPA-RUZDIDTESA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 102000004627 Iduronidase Human genes 0.000 description 2
- 108010003381 Iduronidase Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 238000005277 cation exchange chromatography Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000007421 fluorometric assay Methods 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- KPWDGTGXUYRARH-UHFFFAOYSA-N 2,2,2-trichloroethanol Chemical compound OCC(Cl)(Cl)Cl KPWDGTGXUYRARH-UHFFFAOYSA-N 0.000 description 1
- FJZLFVMQYRJQGF-UHFFFAOYSA-N 2,2,2-trichloroethyl 2-(7-acetyloxy-2-oxochromen-4-yl)acetate Chemical compound ClC(Cl)(Cl)COC(=O)CC1=CC(=O)OC2=CC(OC(=O)C)=CC=C21 FJZLFVMQYRJQGF-UHFFFAOYSA-N 0.000 description 1
- YZVJUVCSBDSVCK-UHFFFAOYSA-N 2,2,2-trichloroethyl 2-(7-hydroxy-2-oxochromen-4-yl)acetate Chemical compound ClC(Cl)(Cl)COC(=O)CC1=CC(=O)OC2=CC(O)=CC=C21 YZVJUVCSBDSVCK-UHFFFAOYSA-N 0.000 description 1
- JTZDWWIAFDWJJY-UHFFFAOYSA-N 2-(7-acetyloxy-2-oxochromen-4-yl)acetic acid Chemical compound OC(=O)CC1=CC(=O)OC2=CC(OC(=O)C)=CC=C21 JTZDWWIAFDWJJY-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- AEMOLEFTQBMNLQ-HNFCZKTMSA-N L-idopyranuronic acid Chemical group OC1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-HNFCZKTMSA-N 0.000 description 1
- 229910013684 LiClO 4 Inorganic materials 0.000 description 1
- 208000015439 Lysosomal storage disease Diseases 0.000 description 1
- 229930182473 O-glycoside Natural products 0.000 description 1
- 150000008444 O-glycosides Chemical class 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 102000005262 Sulfatase Human genes 0.000 description 1
- MKZJHNBRJUVCQF-RMPHRYRLSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-6-fluoro-2-(hydroxymethyl)oxan-3-yl] acetate Chemical compound CC(=O)O[C@H]1[C@H](F)O[C@H](CO)[C@@H](OC(C)=O)[C@@H]1OC(C)=O MKZJHNBRJUVCQF-RMPHRYRLSA-N 0.000 description 1
- LQQAXRAPECFCEH-RMPHRYRLSA-N [(2s,3s,4r,5r,6s)-3,5-diacetyloxy-2-bromo-6-fluoro-2-(hydroxymethyl)oxan-4-yl] acetate Chemical compound CC(=O)O[C@H]1[C@H](F)O[C@](Br)(CO)[C@@H](OC(C)=O)[C@@H]1OC(C)=O LQQAXRAPECFCEH-RMPHRYRLSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 150000002243 furanoses Chemical class 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000937 glycosyl acceptor Substances 0.000 description 1
- 239000000348 glycosyl donor Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 150000003214 pyranose derivatives Chemical class 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- ZFQWJXFJJZUVPI-UHFFFAOYSA-N tert-butyl n-(4-aminobutyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCCN ZFQWJXFJJZUVPI-UHFFFAOYSA-N 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/075—Benzo[b]pyran-2-ones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
【選択図】図1
Description
本出願は、2009年1月12日に出願された米国仮出願番号第61/144,024号の利益を主張するもので、その全体が参照により本明細書に明白に組み込まれる。
本発明は、国立衛生研究所によって認可された契約番号5R01DK067859−09の下で、政府の援助を受けて行われた。政府は、本発明において特定の権利を有する。
反応は、N2雰囲気下で、オーブン乾燥したガラス容器の無水溶媒において実施した。薄層クロマトグラフィを、シリカプレート(シリカゲル60、F−254(0.25mm))上で実施した。1H−NMR化学シフトは、内標準(3.31ppm)としてメタノールピークを使用して、ppm(δ)で報告される。エレクトロスプレイイオン化マススペクトルは、bruker Esquire LC00066イオントラップ分光計で獲得した。フラッシュクロマトグラフィは、シリカゲル(40μmから63μm)を用いて実施した。
(α−L−イズロン酸配糖体メチルエステルの調製)
α−L−イズロン酸配糖体メチルエステル9bの調製を、下に説明し、図2で示す。
(2−硫酸化α−L−イズロン酸配糖体11の調製)
2−硫酸化α−L−イズロン酸配糖体11の調製は、下に説明され、図1に示される。
Claims (19)
- 2位で配糖体を硫酸化するための方法であって、
(a)2位および4位にてシスの関係にあるヒドロキシル基を有する配糖体をスズ試薬で処理して、配糖体である2,4−スタンニレンアセタールを提供することと、
(b)前記2,4−スタンニレンアセタールを硫化剤で処理して、2−硫酸化配糖体を提供することと、
を含む方法。 - 前記2−硫酸化配糖体が、90%を超える選択性で前記2位にて硫酸化される、請求項1に記載の方法。
- 前記2−硫酸化配糖体が、95%を超える選択性で前記2位にて硫酸化される、請求項1に記載の方法。
- 前記配糖体が、イズロン酸配糖体である、請求項1に記載の方法。
- 前記配糖体が、α−L−イズロン酸配糖体である、請求項1に記載の方法。
- 前記スズ試薬がジアルキルスズ(VI)酸化物である、請求項1に記載の方法。
- 前記スズ試薬が酸化ジブチルスズ(IV)である、請求項1に記載の方法。
- 前記硫化剤が三酸化硫黄である、請求項1に記載の方法。
- 前記硫化剤が、三酸化硫黄トリメチルアミン錯体、三酸化硫黄ピリジン錯体、および三酸化硫黄N,N−ジメチルホルムアミド錯体から成る群から選択される三酸化硫黄錯体である、請求項1に記載の方法。
- Mがブチルオキシカルボニル[C4H9OC(=O)−]である、請求項14に記載の方法。
- Lが、−NH−(CH2)n−NHC(=O)CH2−であり、式中、nは1〜8である、請求項14に記載の方法。
- 前記アンモニウムイオンがトリメチルアンモニウムである、請求項14に記載の方法。
- 前記金属イオンがナトリウムイオンである、請求項14に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14402409P | 2009-01-12 | 2009-01-12 | |
US61/144,024 | 2009-01-12 | ||
PCT/US2010/020801 WO2010081163A2 (en) | 2009-01-12 | 2010-01-12 | Method for 2-sulfation of glycosides |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014239293A Division JP5981520B2 (ja) | 2009-01-12 | 2014-11-26 | 配糖体の2−硫酸化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012515168A true JP2012515168A (ja) | 2012-07-05 |
JP5657567B2 JP5657567B2 (ja) | 2015-01-21 |
Family
ID=42317219
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011545532A Active JP5657567B2 (ja) | 2009-01-12 | 2010-01-12 | 配糖体の2−硫酸化方法 |
JP2014239293A Active JP5981520B2 (ja) | 2009-01-12 | 2014-11-26 | 配糖体の2−硫酸化方法 |
JP2016148440A Withdrawn JP2017014236A (ja) | 2009-01-12 | 2016-07-28 | 配糖体の2−硫酸化方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014239293A Active JP5981520B2 (ja) | 2009-01-12 | 2014-11-26 | 配糖体の2−硫酸化方法 |
JP2016148440A Withdrawn JP2017014236A (ja) | 2009-01-12 | 2016-07-28 | 配糖体の2−硫酸化方法 |
Country Status (5)
Country | Link |
---|---|
US (3) | US8802833B2 (ja) |
EP (1) | EP2385950B1 (ja) |
JP (3) | JP5657567B2 (ja) |
ES (1) | ES2464123T3 (ja) |
WO (1) | WO2010081163A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2385950B1 (en) * | 2009-01-12 | 2014-03-12 | University Of Washington | Method for 2-sulfation of glycosides |
CN105636606B (zh) | 2013-09-05 | 2021-03-12 | 华盛顿大学商业中心 | 用于筛查mps i、ii、iiia、iiib、iva、vi和vii的试剂和方法 |
CA3017527A1 (en) | 2016-03-25 | 2017-09-28 | Seattle Genetics, Inc. | Process for the preparation of pegylated drug-linkers and intermediates thereof |
JP2020512312A (ja) * | 2017-03-24 | 2020-04-23 | シアトル ジェネティックス, インコーポレイテッド | グルクロニド薬物−リンカーの調製のためのプロセスおよびその中間体 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10502093A (ja) * | 1994-07-27 | 1998-02-24 | ジェンザイム・リミテッド | レジオ選択的硫酸化 |
US5783693A (en) * | 1993-11-19 | 1998-07-21 | The Regents Of The University Of California | Methods for synthesizing sulfated disaccharide inhibitors of selectins |
US6184196B1 (en) * | 1998-05-27 | 2001-02-06 | University Of Iowa Research Foundation | Sucrose based surfactants and methods thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2385950B1 (en) * | 2009-01-12 | 2014-03-12 | University Of Washington | Method for 2-sulfation of glycosides |
-
2010
- 2010-01-12 EP EP10729677.4A patent/EP2385950B1/en active Active
- 2010-01-12 JP JP2011545532A patent/JP5657567B2/ja active Active
- 2010-01-12 US US13/144,048 patent/US8802833B2/en active Active
- 2010-01-12 WO PCT/US2010/020801 patent/WO2010081163A2/en active Application Filing
- 2010-01-12 ES ES10729677.4T patent/ES2464123T3/es active Active
-
2014
- 2014-08-11 US US14/456,822 patent/US9481701B2/en active Active
- 2014-11-26 JP JP2014239293A patent/JP5981520B2/ja active Active
-
2016
- 2016-07-28 JP JP2016148440A patent/JP2017014236A/ja not_active Withdrawn
- 2016-09-29 US US15/280,699 patent/US20170233426A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783693A (en) * | 1993-11-19 | 1998-07-21 | The Regents Of The University Of California | Methods for synthesizing sulfated disaccharide inhibitors of selectins |
JPH10502093A (ja) * | 1994-07-27 | 1998-02-24 | ジェンザイム・リミテッド | レジオ選択的硫酸化 |
US6184196B1 (en) * | 1998-05-27 | 2001-02-06 | University Of Iowa Research Foundation | Sucrose based surfactants and methods thereof |
Non-Patent Citations (1)
Title |
---|
JPN6014020061; Carbohydrate Research 344(1), 20090105, p.21-28 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010081163A3 (en) | 2010-12-02 |
US9481701B2 (en) | 2016-11-01 |
JP5657567B2 (ja) | 2015-01-21 |
US8802833B2 (en) | 2014-08-12 |
US20150158900A1 (en) | 2015-06-11 |
WO2010081163A2 (en) | 2010-07-15 |
EP2385950B1 (en) | 2014-03-12 |
EP2385950A2 (en) | 2011-11-16 |
JP2017014236A (ja) | 2017-01-19 |
JP5981520B2 (ja) | 2016-08-31 |
ES2464123T3 (es) | 2014-05-30 |
US20110288281A1 (en) | 2011-11-24 |
JP2015091814A (ja) | 2015-05-14 |
US20170233426A1 (en) | 2017-08-17 |
EP2385950A4 (en) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004509902A5 (ja) | ||
JP5981520B2 (ja) | 配糖体の2−硫酸化方法 | |
EP2382226B1 (en) | Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof | |
Adibekian et al. | De novo synthesis of uronic acid building blocks for assembly of heparin oligosaccharides | |
JP2010285446A (ja) | 免疫エフェクターのアミノアルキルグルコサミニドホスフェートおよびジサッカライドの製造方法、ならびにその中間体 | |
Mishra et al. | Synthesis of the hyper-branched core tetrasaccharide motif of chloroviruses | |
AU704248B2 (en) | Regioselective sulfation | |
Patel et al. | Synthesis of substrate analogues as potential inhibitors for Mycobacterium tuberculosis enzyme MshC | |
TW202334175A (zh) | 新穎寡糖、該寡糖之製造中間體及其等之製造方法 | |
EP1829884B1 (en) | Sugar donor | |
Amin et al. | Synthesis of asparagine-linked bacillosamine | |
Blanchard et al. | Short synthetic sequence for 2-sulfation of α-l-iduronate glycosides | |
Ogawa et al. | Synthesis and enzyme-inhibitory activity of methyl acarviosin analogues having the α-manno configuration | |
US10759823B2 (en) | Regioselective silyl exchange of per-silylated oligosaccharides | |
Chu et al. | Efficient synthesis of a linear octyl pentaarabinofuranoside, a substrate for mycobacterial EmbA/EmbB proteins | |
US10640526B2 (en) | Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose | |
JPH02292295A (ja) | エトポシドの製造方法 | |
Zhang et al. | Regio-and stereoselective anomeric esterification of glucopyranose 1, 2-diols and a facile preparation of 2-O-acetylated glucopyranosyl trichloroacetimidates from the corresponding 1, 2-diols | |
JP5015505B2 (ja) | コア4型構造を有するo−結合型糖タンパク質糖鎖関連化合物およびその製造方法 | |
JPH11279192A (ja) | 新規なクロマノール配糖体の製造方法 | |
Niedbal | Method Development in the Regioselective Glycosylation of Unprotected Carbohydrates | |
JP2006522772A (ja) | コンビナトリアル・ライブラリのための新規な基本骨格としての縮合オキサビサイクリックアミノアルコール | |
Abel et al. | Synthesis of an aryl 2-deoxy-β-glycosyl tetrasaccharide to probe retaining endo-glycosidase mechanism | |
Gómez | 2.1 Reactions at Oxygen Atoms | |
JPH09286793A (ja) | 環状シリルエーテル型保護基を用いたグリコシル化合物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130111 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140520 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140818 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141028 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141126 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5657567 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |